At the same time, PTXL also reduced the production of fibrosis cytokines including TNF-α, IL-6 and TGF-β by inhibiting Akt/GSK3β signaling pathway, thus preventing the fibrosis process of keloid (M. Wang M. et al., 2019). The gene discussed is IL6; the disease is keloid.